BETWEENProcess Development and Manufacturing Agreement • May 15th, 2002 • Xoma LTD /De/ • Pharmaceutical preparations
PROCESS DEVELOPMENT AND MANUFACTURING AGREEMENTProcess Development and Manufacturing Agreement • September 24th, 2009 • Prana Biotechnology LTD • Pharmaceutical preparations • England
This PROCESS DEVELOPMENT AND MANUFACTURING AGREEMENT (hereinafter “Agreement”) is made by and between Prana Biotechnology Ltd ACN 080 699 065 (“Prana”), a company incorporated in Australia whose registered office and principal place of business is at Level 2,369 Royal Parade, Parkville Victoria 3052 and Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s”), a company incorporated and existing under the laws of India, having its principal place of business at 7-1-27 Ameerpet Hyderabad 500 016 India.
AMENDMENT #1 TO THEProcess Development and Manufacturing Agreement • August 13th, 2002 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Amendment #1 to the Process Development and Manufacturing Agreement (the “Amendment”) is made and entered into on April 15, 2002 by and between ONYX Pharmaceuticals, Inc., a Delaware Corporation having its principal place of business at 3031 Research Drive, Richmond, California 94806 (“ONYX”), and XOMA (US) LLC, a Delaware limited liability company (“XOMA”) with offices at 2910 Seventh Street, Berkeley, California 94710. ONYX and XOMA are sometimes referred to herein individually as a “Party” and collectively as “Parties.”
